ClearPoint Neuro, Inc. (NASDAQ:CLPT) Q4 2025 Earnings Call Transcript March 17, 2026 ClearPoint Neuro, Inc. misses on earnings expectations. Reported EPS is $-0.27498 EPS, expectations were $-0.2.
Delivered record-high revenues, Adjusted EBITDA 1 , Adjusted EBITDA per shar e 1 since inception Generated record high cash flow from operations ...
Academy Sports and Outdoors, Inc. (NASDAQ:ASO) Q4 2025 Earnings Call Transcript March 17, 2026 Academy Sports and Outdoors, Inc. misses on earnings expectations. Reported EPS is $1.97 EPS, ...
They dress like it’s the Industrial Revolution, but they’re very online denizens of the anti-woke manosphere. And they want ...
Nemesis gets a Summer 2026 release. Check streaming details, plot, teaser, and full character list in this complete fan guide ...
As we shared last year, to support Sera Prognostics, Inc.'s next phase of commercialization, we strengthened our leadership team with Lee Anderson joining us as Chief Commercial Officer and Doctor ...
Susan Gilkerson, a math teacher and school bus driver, stood before a South Dakota education board and issued a warning. The proposed math standards the board was considering — just 36 pages, less ...
Company to host enhanced first quarter fiscal 2026 results conference call in June providing multi-year financial framework post closing of the ...
Q4 2025 Earnings Call March 18, 2026 4:30 PM EDTCompany ParticipantsAnkit HiraJeffrey Thompson - Founder, President, CEO ...
Soligenix Announces HyBryte™ Clinical Summary Published in "Expert Opinion on Investigational Drugs"
(Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, ...
Welcome to Sera Prognostics fourth quarter and full fiscal year 2025 earnings conference call. At the close of mar ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results